Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is modest, but has potential. We plan to hang with our short people, catch up on some reading, and spend time with a few family favorites. And what about you? Are you leaving for a summer getaway? Whether or not, this remains a lovely time to enjoy the great outdoors. Remember, beaches, lakes, and mountains are beckoning. You could visit someone special. Take a long drive in the country. Or if you feel mischievous, you can place a bet on when or if you-know-who recognizes the effect a trade war has on the economy. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

Centers for Medicare and Medicaid Services Administrator Seema Verma says the Trump administration is pushing forward with a controversial proposal to lower drug prices, despite opposition from some fellow Republicans, The Hill reports. Verma told reporters that the proposal to lower certain drug prices in Medicare by tying them to lower prices in other countries, known as the international price index, is a “top priority.” The pharmaceutical industry and many congressional Republicans warn that the move amounts to “price controls.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.